CoChat

Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse

Open access
González, Sara, Valenti, Marta, de Miguel, Rosario, Fezza, Filomena, Fernández‐Ruiz, Javier, Di Marzo, Vincenzo, Ramos, José A · 2004 · British Journal of Pharmacology

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

Chronic alcohol exposure modifies endocannabinoid levels in different brain regions, while pharmacological targeting of the endocannabinoid system has been reported to influence ethanol intake in laboratory animals. The present study was aimed at evaluating the pattern of changes of endocannabinoids and their receptors, with emphasis on reward‐related brain areas, in Wistar rats subjected to consecutive phases of alcoholization, alcohol deprivation (abstinence), and voluntary consumption of alcohol (relapse). We observed that, in the limbic forebrain, anandamide (AEA) and 2‐arachidonoylglycerol (2‐AG) contents increased after 7 days of alcoholization, then to dramatically decrease after 48 h of alcohol deprivation and, in the case of 2‐AG, to further decrease when rats were allowed to relapse to alcohol consumption. By contrast, in the midbrain, there was a marked reduction in AEA, but not 2‐AG, content, after alcoholization. This decrease was not affected during alcohol abstinence, but both AEA and 2‐AG contents were then significantly reduced when rats were allowed to relapse to alcohol consumption. Based on these data, we examined whether pharmacological activation/blockade of endocannabinoid transmission might influence ethanol intake in rats allowed to relapse to alcohol consumption after subsequent periods of alcoholization and alcohol deprivation. Treatment with either Δ 9‐tetrahydrocannabinol or CP55,940, two cannabinoid agonists, reduced both total liquid and ethanol intake but did not affect ethanol preference. Treatment with SR141716, a selective cannabinoid CB 1 receptor antagonist, also produced a significant reduction in both total liquid and ethanol intake without affecting ethanol preference. Accordingly, none of these effects on ethanol intake were accompanied by changes in dopamine and GABA in limbic structures. In summary, the levels of endocannabinoids underwent significant changes in reward‐related areas during alcoholization, alcohol deprivation, and relapse, showing the lowest values in this latter phase. Treatment with cannabinoid agonists or a selective CB 1 receptor antagonist resulted in a reduction of ethanol intake by rats allowed to relapse to alcohol consumption after periods of alcoholization and alcohol deprivation, but these effects did not appear to be due to changes in neurobiological substrates currently involved in alcohol reinforcement/relapse. British Journal of Pharmacology (2004) 143, 455–464. doi:10.1038/sj.bjp.0705963

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0705963

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Research works printed but not linked: 2

  1. 10.1111/j.1530-0277.2001.tb02209.x · doi:10.1111/j.1530-0277.2001.tb02209.x · Paper page
  2. 10.1111/j.1530-0277.2001.tb02353.x · doi:10.1111/j.1530-0277.2001.tb02353.x · Paper page

Cited by

See all 92

Metadata

Authors
González, S., Valenti, M., de Miguel, R., Fezza, F., Fernández‐Ruiz, J., Di Marzo, V., & Ramos, J. A.
Affiliations
  • Universidad Complutense de Madrid (ES)
  • Istituto di Chimica Biomolecolare (IT)
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2004-10
Volume
143
Issue
4
Pages
455-464
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2095302802
Cited by
79
References
61
Citations by year
2026: 1 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 5 · 2014: 4 · 2013: 5 · 2012: 4
FWCI
4.61
Type
journal article
Language
en
Open access
Locations
  • British Journal of Pharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords
endocannabinoid system, alcohol relapse, chronic ethanol exposure, alcohol deprivation, anandamide, 2-arachidonoylglycerol, CB1 receptor, delta-9-tetrahydrocannabinol, CP55,940, SR141716, ethanol consumption, ethanol preference, brain reward system, limbic forebrain, midbrain, dopamine, GABA
MeSH terms
Ethanol, Alcoholism, Animals, Brain, Male, Reward, Rats, Wistar, Receptor, Cannabinoid, CB1, Rats, Secondary Prevention, Cannabinoid Receptor Modulators, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.